ESC 365
Menu
Home
Search
Events
About
ESC Platforms
Escardio.org
ESC 365
ESC eLearning
Create an account
Sign in
Back
ESC Premium Access
Applying ODYSSEY Outcomes in your clinical practice - Who are the most appropriate patients for PCSK9 inhibitor treatment?
Session:
Applying ODYSSEY Outcomes in your clinical practice - Who are the most appropriate patients for PCSK9 inhibitor treatment?
Topic:
Treatment
Speaker:
Professor G. Schwartz (Aurora, US)
Sponsored by Sanofi and Regeneron
Event:
ESC Congress 2019
Congress Presentation
Sign in for access options
Sign in for access options
About the speaker
Professor Gregory Schwartz
University of Colorado School of Medicine, Aurora (United States of America)
2
presentations
0
follower
Access the full session
Applying ODYSSEY Outcomes in your clinical practice - Who are the most appropriate patients for PCSK9 inhibitor treatment?
Speakers:
Professor G. Schwartz
Access
About the event
ESC Congress 2019
31 August - 4 September 2019
Sessions
Presentations
ESC 365 is supported by
Explore sponsored resources